Sign In
Buy BBI
$1.94
+0 (+0%)
At Close: Feb 07, 2023
Brickell Biotech Reports First Quarter 2020 Financial Results and Provides Corporate Update | MarketScreener
08:02pm, Wednesday, 13'th May 2020Brickell Biotech Reports First Quarter 2020 Financial Results and Provides Corporate Update
08:01pm, Wednesday, 13'th May 2020
Brickell Biotech, Inc. (“Brickell”) (BBI), a clinical-stage pharmaceutical company focused on developing innovative and differentiated prescription therapeutics for the treatment of debilitating s
The Daily Biotech Pulse: Gilead Signs Manufacturing Deal For Remdesivir, Bristol-Myers Gets Refuse-To-File Letter
12:00am, Wednesday, 13'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 12)
Acceleron Pharma Inc (NASDAQ...
Brickell Biotech to Report First Quarter 2020 Financial Results on May 13, 2020 | MarketScreener
08:06pm, Monday, 04'th May 2020Brickell Biotech to Report First Quarter 2020 Financial Results on May 13, 2020
08:05pm, Monday, 04'th May 2020
Brickell Biotech, Inc. (“Brickell”) (BBI), a clinical-stage pharmaceutical company focused on developing innovative and differentiated prescription therapeutics for the treatment of debilitating s
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs March 19.) * Biomerica, Inc. (NASDAQ: BMRA) * Centogene NV (
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs March 19.)
Biomerica, Inc. (NASDAQ...
Brickell Biotech Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update
08:01pm, Wednesday, 18'th Mar 2020
BOULDER, Colo., March 18, 2020 -- Brickell Biotech, Inc. (“Brickell”) (Nasdaq: BBI), a clinical-stage pharmaceutical company focused on developing innovative and differentiated.
Brickell Biotech Inc to Host Earnings Call
06:30pm, Wednesday, 18'th Mar 2020
NEW YORK, NY / ACCESSWIRE / March 18, 2020 / Brickell Biotech Inc (NASDAQ:BBI) will be discussing their earnings results in their 2019 Fourth Quarter Earnings call to be held on March 18, 2020 at 4:30
The Daily Biotech Pulse: AbbVie, Allergan Agree On Divestments, Obalon Stops Obesity Balloon Sale, COVID-19 Updates
11:36am, Wednesday, 18'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 17) * BioNTech SE - ADR (NASDAQ: BNTX) * Regeneron P
The Week Ahead In Biotech: COVID-19 Updates, Tapering Earnings Flow, Eton's Seizure Drug Review
01:55pm, Sunday, 15'th Mar 2020
The biopharma space bled along with the rest of the market and COVID-19 levered biotechs weren't spared either.Biogen Inc (NASDAQ: BIIB) was in the news for all wrong reasons, as an employee conferenc
Assetz Capital is First Property Marketplace to Receive Funding from British Business Investments
07:39pm, Saturday, 14'th Mar 2020
Assetz Capital has received £15 million in funding from British Business Investments (BBI). According to Assetz Capital, this is the first time a property-focu
Reviewing Jounce Therapeutics (NASDAQ:JNCE) and Vical (NASDAQ:VICL)
05:20am, Thursday, 12'th Mar 2020
Vical (NASDAQ:VICL) and Jounce Therapeutics (NASDAQ:JNCE) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their pro
Brickell Biotech to Report Fourth Quarter and Full Year 2019 Financial Results on March 18, 2020
08:05pm, Monday, 09'th Mar 2020
Brickell Biotech, Inc. (“Brickell”) (BBI), a clinical-stage pharmaceutical company focused on developing innovative and differentiated prescription therapeutics for the treatment of debilitating s
